STRYKER CORP Interest Income Interest Earning Asset
STRYKER CORP (SYK) reported Interest Income Interest Earning Asset of $26.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeInterestEarningAsset · last filed 2026-07-31
- STRYKER CORP interest income interest earning asset for the quarter ending 2026-06-30 was $26.00M, a 8.33% increase year-over-year.
- STRYKER CORP interest income interest earning asset for the quarter ending 2026-03-31 was $34.00M, a 10.53% decline year-over-year.
- STRYKER CORP interest income interest earning asset for the quarter ending 2025-12-31 was $31.00M, a 34.04% decline year-over-year.
- STRYKER CORP interest income interest earning asset for the quarter ending 2025-09-30 was $28.00M, a 6.67% decline year-over-year.
- STRYKER CORP interest income interest earning asset for fiscal 2025 was $121.00M, a 12.95% decline from fiscal 2024.
- STRYKER CORP interest income interest earning asset for fiscal 2024 was $139.00M, a 85.33% increase from fiscal 2023.
- STRYKER CORP interest income interest earning asset for fiscal 2023 was $75.00M, a 200.00% increase from fiscal 2022.
- STRYKER CORP interest income interest earning asset for fiscal 2022 was $25.00M, a 66.67% increase from fiscal 2021.
| Period end | Interest Income Interest Earning Asset 3 month | Interest Income Interest Earning Asset 6 month | Interest Income Interest Earning Asset 9 month | Interest Income Interest Earning Asset 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.00M 10-Q · filed 2026-07-31 | $60.00M 10-Q · filed 2026-07-31 | $91.00M derived: sum of 3 quarters · filed 2026-07-31 | $119.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $34.00M 10-Q · filed 2026-05-11 | $65.00M derived: sum of 2 quarters · filed 2026-05-11 | $93.00M derived: sum of 3 quarters · filed 2026-05-11 | $117.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $59.00M derived: sum of 2 quarters · filed 2026-02-11 | $83.00M derived: sum of 3 quarters · filed 2026-07-31 | $121.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $28.00M 10-Q · filed 2025-10-31 | $52.00M derived: sum of 2 quarters · filed 2026-07-31 | $90.00M 10-Q · filed 2025-10-31 | $137.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $24.00M 10-Q · filed 2026-07-31 | $62.00M 10-Q · filed 2026-07-31 | $109.00M derived: sum of 3 quarters · filed 2026-07-31 | $139.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $38.00M 10-Q · filed 2026-05-11 | $85.00M derived: sum of 2 quarters · filed 2026-05-11 | $115.00M derived: sum of 3 quarters · filed 2026-05-11 | $141.00M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $77.00M derived: sum of 2 quarters · filed 2026-02-11 | $103.00M derived: sum of 3 quarters · filed 2026-02-11 | $139.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | $30.00M 10-Q · filed 2025-10-31 | $56.00M derived: sum of 2 quarters · filed 2025-10-31 | $92.00M 10-Q · filed 2025-10-31 | |
| 2024-06-30 | $26.00M 10-Q · filed 2025-08-01 | $62.00M 10-Q · filed 2025-08-01 | ||
| 2024-03-31 | $36.00M 10-Q · filed 2025-05-02 | |||
| 2023-12-31 | $75.00M 10-K · filed 2026-02-11 | |||
| 2022-12-31 | $25.00M 10-K · filed 2025-02-12 | |||
| 2021-12-31 | $15.00M 10-K · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |